Vinay Prasad and Tracy Beth Høeg mix skepticism with new ways to define risk in pursuing sweeping changes to vaccine policy at the FDA.

The RSV vaccine is specifically created and approved for administration in older adults. Back in March, the FDA recommended ...

Among the most commonly cited reasons for COVID vaccine hesitation are fears about side effects, long-term health ...

A new study has identified three existing medications that could be repurposed to treat or prevent Alzheimer's disease.

On August 22, 2025, the U.S. Food and Drug Administration’s Center for Biologics Evaluation and Research (CBER) suspended the biologics license for IXCHIQ, a live-attenuated chikungunya vaccine, ...

The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...

New federal guidance surrounding COVID vaccine authorization could make it more difficult for many people to be inoculated against the circulating — and, now, seasonally spiking — coronavirus. Under ...

The Food and Drug Administration's approvals for the latest round of COVID-19 shots restrict the shots to people at higher risk of complications from COVID. The Food and Drug Administration approved ...

Researchers say more study is needed, but early results suggest the century-old vaccine could become a powerful new tool in ...

Every day, millions of patients and families do their best to make the right health care decisions for themselves and their loved ones. This cannot happen without the freedom to choose from a wide ...

A FREE NHS jab could be the most promising drug yet to stop Alzheimer’s, experts say. The shingles vaccine emerged as the strongest contender after researchers reviewed 80 existing medicines to ...